Follow-Up From Overseas: A Continuity-of-Care Guide

One leaves Gangnam the way one leaves a well-run hotel — with a folder, a card, and the quiet sense that the conversation is not, in fact, finished. Continuity of care is the half of regenerative medicine the consultation room rarely advertises and the careful clinic always provisions for. The injection is a single afternoon; the response unfolds across months. 返到屋企之後, a Hong Kong friend once put it to me, 先至係真正開始 — the real work begins when one is home. The Seoul rooms one returns to are the rooms that have already drafted the schedule, prepared the bilingual letter, and named the local physician they will write to.

Why follow-up matters more than the consultation suggests

Follow-up, in autologous regenerative medicine, is the longer act of the procedure — and the act in which the early modulation, the late tissue response, and any uncommon sequelae are characterised. The injection itself is a discrete event, traceable to a thirty-minute window on a single afternoon; the biological response unfolds over a six-month, twelve-month, twenty-four-month arc that the clinic cannot, by geography alone, supervise in person for an international patient. The careful clinic accepts this asymmetry and works around it. The follow-up schedule, in our reading of the better Seoul protocols, is layered: a forty-eight to seventy-two hour check before departure, an early-week-two photographic and symptomatic review by encrypted upload, a six-week consolidation review, a three-month evaluation against the indication's expected trajectory, a six-month re-assessment, and a twelve-month closing review with the option of in-person re-consultation if the patient is back in Seoul. Each touchpoint exists for a clinical reason rather than a hospitality one. The early checks catch the small subset of injection-site reactions that benefit from a same-week intervention. The six-week and three-month reviews track the indication's natural-history curve against the published cohort data. The six-month and twelve-month reviews confirm that the response has stabilised within the expected window or, in the smaller fraction of cases, identify the variance early enough to be useful. The patients who return for the in-person twelve-month review are not, in our reading, treating it as ceremonial. They are treating it as the proper close of a course of care that began with a folder, a card, and a quiet handshake.

The folder one flies home with — what it contains and why

The discharge folder is the principal continuity-of-care instrument the careful Seoul clinic prepares, and a thoughtful one is recognisable on opening it. The bilingual procedure summary — Korean and the patient's home language, printed on letterhead, dated, signed — is the document that allows a local physician at home to read into what was done. It identifies the indication, the harvest site, the harvest volume, the processing protocol, the cell preparation type and the resuspension volume, the injection sites and depths, the operator's name and licence number, the consenting paperwork the patient signed, and the immediate post-procedure observation note. A separate page lists the medications dispensed, the medications paused, and the medications resumed; the dressing protocol; the activity restriction window; and the warning-sign list with the clinic's direct after-hours number. A third page lists the follow-up schedule, the platform on which encrypted uploads are reviewed, the named coordinator, the time zones at which the coordinator is reachable, and the indication-specific photographic protocol the patient is to follow at home. A laminated wallet card, a quiet hospitality flourish, lists the procedure date, the harvest site, the cell type, and a QR code linking to the consenting paperwork. The folder is, in the rooms one returns to, prepared without the patient asking — a small detail, but a useful one when one is parsing the difference between a clinic that runs continuity and a clinic that gestures at it. The Korean Ministry of Health and Welfare's [foreign-patient framework](https://www.mohw.go.kr/eng/) sets minimum documentation standards for international patient records; the better clinics, in our reading, exceed those standards rather than meet them.

The schedule — six touchpoints across twelve months

The follow-up schedule is the spine of overseas continuity, and the better protocols arrange it as a layered sequence rather than as a single distant appointment. The first touchpoint is the forty-eight to seventy-two hour pre-departure review, conducted in person at the clinic before the patient flies; this is the window in which the early injection-site response is at its most reactive and the moment at which any small intervention — a re-dressing, a precautionary antibiotic, a deferred travel by twenty-four hours — is most efficiently made. The second touchpoint is the early-week-two encrypted photographic review, in which the patient uploads a defined set of images on a defined platform and the clinic reviews them within forty-eight hours. The third touchpoint is the six-week consolidation review, typically a thirty-minute video consultation conducted at a time the coordinator pre-schedules across time zones. The fourth touchpoint is the three-month evaluation, which combines a structured photographic upload with a symptom-questionnaire and, for orthopaedic indications, a functional self-assessment instrument. The fifth touchpoint is the six-month re-assessment, occasionally augmented by an imaging study performed at home and uploaded to the clinic for review. The sixth and closing touchpoint is the twelve-month review, ideally in person if the patient is travelling back through Seoul, by video consultation if not. Patients report — and the clinic notes, in its in-house data — that the schedule's layered cadence is the part of the protocol they value most. The cadence catches what a single distant appointment would miss. It also, candidly, sustains the relationship between the patient and the clinic in the months when the patient is most likely to wonder whether the response is unfolding as it should.

Working with a physician at home — the bilingual letter and the soft handover

A continuity-of-care plan that depends on the Seoul clinic alone is, in honest editorial terms, an incomplete one. The careful protocol assumes the patient has, or will identify, a local physician at home — a primary-care doctor, an internist, a sports-medicine consultant, a dermatologist appropriate to the indication — to whom the Seoul clinic can address its handover. The bilingual procedure summary letter is the principal instrument of this handover. The letter is addressed to the named local physician, not to a generic 'to whom it may concern,' and it is written in the register a clinical peer would recognise: the indication, the rationale for the regenerative approach, the specifics of the cell preparation, the operator's clinical reasoning for the injection sites and depths, the expected response trajectory, the published evidence base for that trajectory, the warning signs that should prompt re-contact with the Seoul clinic, and the contact details for the operator's direct line. The soft handover is the second instrument: the Seoul coordinator, with the patient's consent, sends a brief introductory email to the local physician confirming receipt of the patient's records and offering a single thirty-minute video consultation between the two clinicians at no charge. Patients report — and the local physicians the clinic has worked with confirm — that the soft handover does the bulk of the relationship-building work, with the local physician reading the letter more carefully once it has been introduced personally. The clinic that volunteers this handover without the patient asking is the clinic one returns to. The clinic that treats the handover as a paid premium tier is the clinic one questions. 呢個唔係客套, the discreet Hong Kong physicians one consults in this space agree — this is not a courtesy but a clinical baseline, and the rooms that miss it miss something important.

The encrypted-upload protocol — what one photographs and how often

Encrypted photographic and symptomatic upload is the mechanism by which the careful Seoul clinic remains usefully present during the six-week consolidation window without requiring travel. The platform varies by clinic — a HIPAA-aligned messaging service, a clinic-branded patient portal, a region-specific app — but the protocol underneath is recognisable. The patient is given a defined set of camera angles, lighting conditions, and reference markers at discharge; the photographs are uploaded on a defined cadence (typically days three, seven, fourteen, twenty-eight, and forty-two for aesthetic indications, with orthopaedic indications adding a structured functional video at the four and six-week marks); the clinic acknowledges receipt within a published service-level window and returns a written review within forty-eight to seventy-two hours; and any image that triggers a clinical concern prompts a same-day video consultation rather than waiting for the next scheduled touchpoint. The protocol is, importantly, asymmetric. The patient uploads more than the clinic returns; the clinic returns less in volume but more in clinical density. A 2021 review in the Journal of Telemedicine and Telecare examining post-procedural photographic monitoring across cosmetic and minor-surgical applications reported that structured tele-follow-up protocols achieved adherence rates of seventy to eighty-five per cent at six weeks, with the better-performing programmes characterised by clear instructional materials, scheduled reminder cadences, and a named coordinator the patient could reach by direct message. The Seoul rooms that have read this literature, in our reading of their protocols, build it in. The rooms that have not, in some cases, treat the encrypted upload as a marketing flourish rather than as a clinical instrument; the difference shows up in the second month.

Imaging at home — when, where, and how to share it

Imaging is, for a subset of indications, part of the longer follow-up arc, and the careful clinic prepares the patient for it rather than leaving it to chance. Orthopaedic indications — knee, shoulder, disc — typically include a baseline imaging study performed in Seoul before the procedure and a follow-up study performed at home at three or six months, with the imaging modality matched to the indication: standard weight-bearing radiographs for the joint indications, magnetic resonance imaging for the soft-tissue and disc indications. Aesthetic indications more often rely on standardised photography rather than on imaging, with the occasional ultrasound assessment of dermal-thickness change for the patients participating in the clinic's longer-term outcomes registry. The cross-border practical question is where to perform the home-side imaging. The Seoul coordinator, in the better protocols, identifies a small number of imaging facilities in the patient's home city — typically by referral pattern from previously discharged patients — and provides the imaging-acquisition protocol the home facility is to follow, including the slice thickness, the field of view, the sequence parameters for MRI, and the patient-positioning details for radiographs. The images are uploaded to a clinic portal or shared on a clinical-imaging platform, reviewed by the operator and, where indicated, by a musculoskeletal radiologist with whom the clinic maintains a working relationship. Patients report the imaging step is the touchpoint most likely to slip in self-managed continuity, and the clinics that schedule, prompt, and confirm the imaging step are the clinics whose data registries are populated and whose long-term outcomes literature is contributable. The clinics that do not are clinics whose follow-up is, in editorial terms, decorative.

How follow-up protocols compare across modalities and origins

Different regenerative-medicine pathways and different originating jurisdictions produce different continuity-of-care expectations, and the differences are larger than the consumer-facing brochures suggest. Below — categorically, not as a ranking — is how the follow-up registers read across the modalities and corridors a Seoul-bound patient is likely to compare. The table is descriptive; the choice between corridors is shaped by indication, regulatory environment, and the patient's own preferences for cadence and documentation, not by marketing positioning.

What to ask before you fly — and what to confirm before you discharge

The continuity-of-care plan is the section of the consultation one ought to read before signing the consent paperwork, not after. The questions a thoughtful patient raises in advance — and a careful clinic answers in writing — include the structure of the post-procedure schedule, the named coordinator and their working hours in the patient's home time zone, the encrypted-upload platform and its data-handling policy, the protocol for imaging at home if applicable, the bilingual letter the clinic will prepare for the local physician, the soft-handover offer and its scope, and the clinic's policy on re-consultation should an unexpected event arise. At discharge, the patient confirms receipt of the discharge folder, the laminated card, the dressing protocol, the warning-sign list, the after-hours number, and the first scheduled upload date. Patients report — and the better clinics' in-house data confirms — that the patients with the most settled six-month outcomes are not, on average, the patients with the most photogenic injection days. They are the patients with the most conscientious follow-up cadences. What recommends a clinic for the international patient is not the décor of the lobby — though that, too, is part of the read — but the cadence of the conversation that begins after the patient lands at home. The room that has already drafted that cadence is the room one returns to. The room that has not is, candidly, the room one declines.

“Continuity of care is the half of regenerative medicine the consultation room rarely advertises and the careful clinic always provisions for; the injection is a single afternoon, and the response unfolds across months — the rooms one returns to are the rooms that have already drafted the schedule, prepared the bilingual letter, and named the local physician they will write to.”

Liu Mei-Hua, on the editorial responsibility of overseas follow-up

Frequently asked questions

How soon after my procedure should I plan to fly home?

Most autologous protocols permit air travel from the day after the procedure, with a forty-eight to seventy-two hour pre-departure check at the clinic strongly recommended; this window catches the early injection-site reactions that benefit from a same-week intervention. Orthopaedic indications and longer-distance flights occasionally merit a third night in Seoul. The standard travel precautions for prolonged sitting — hydration, ankle exercises, compression — apply throughout. The careful clinic confirms the discharge clearance in writing rather than verbally.

What happens at the early-week-two encrypted upload review?

The patient uploads a defined set of photographs — and, for orthopaedic indications, a structured functional video — on the platform the clinic provided at discharge. The clinic acknowledges receipt within a published service window and returns a written review within forty-eight to seventy-two hours. Any image triggering a clinical concern prompts a same-day video consultation rather than waiting for the next scheduled touchpoint. Patients report the review as the moment the cross-border continuity registers as real.

Will the Seoul clinic communicate with my doctor at home?

The careful Seoul protocol prepares a bilingual procedure summary letter addressed to a named local physician and offers a soft handover by introductory email and, with consent, a single thirty-minute video consultation between the two clinicians at no charge. The handover is the principal instrument by which the local physician is brought into the continuity arc. The clinic that volunteers this handover without prompting is the clinic to retain. The clinic that treats it as a premium add-on is the clinic to question.

What if I have a complication after I am back home?

The discharge folder lists the operator's direct after-hours number, the named coordinator's contact details across time zones, and the warning-sign list that should prompt immediate contact. For events requiring same-day attention the patient is advised to be evaluated locally first — at an emergency department or urgent-care clinic — and to share the bilingual letter and the discharge folder with the attending physician, while concurrently notifying the Seoul clinic so the operator can be reached for clinical-peer consultation.

How is the imaging-at-home step coordinated?

For indications that include a follow-up imaging study, the Seoul coordinator typically identifies a small number of imaging facilities in the patient's home city by referral pattern, provides the acquisition protocol the home facility is to follow, and arranges the upload pathway by which the images are returned to the clinic for review by the operator and, where indicated, a musculoskeletal radiologist. Patients arrange the appointment locally, present the printed protocol to the home facility, and confirm the upload completes.

Is the twelve-month in-person review necessary, or sufficient by video?

Either is acceptable in most protocols, though the in-person twelve-month review carries a small clinical advantage where the indication benefits from physical examination — palpation of injected tissue, joint range-of-motion testing, dermal-texture assessment — that video does not fully reproduce. Patients re-routing through Seoul on other travel often combine the review with a short trip; patients for whom that is impractical complete the review by video without prejudice to the clinical assessment, with the clinic flagging anything physical examination would otherwise have caught.

What does the encrypted-upload platform look like and how is my data handled?

The platform varies by clinic — a HIPAA-aligned messaging service, a clinic-branded patient portal, a region-specific application — but the data-handling baseline is consistent: encryption in transit and at rest, access limited to the named clinical team, retention windows aligned with Korean medical-records law, and the patient's right to export and delete their data on request. The discharge folder lists the platform's data-handling policy in the patient's home language and the named coordinator answers questions about it before discharge rather than after.